GrandOmics Of Beijing Raises $14 Million For Third-Gen Sequencing

GrandOmics, a Beijing third-generation sequencing company, raised $14 million in an A funding round led by Matrix Partners China and SAIF Partners, and joined by Zero2IPO. GrandOmics has two divisions, NextOmics for biomedical research and GrandOmics for clinical diagnostics. The company was founded in 2015 by Depeng Wang and Kai Wang, both industry veterans. GrandOmics says the long reads of third-gen sequencing produce more information with fewer errors.